Evidence map›Paper›PMID 37927688›Full record

ArticleCureus2023

Effect of Ocular Dominance on Ocular Blood Flow Parameters.

Yuta Nakaniida, Fumiko Higashikawa, Kana Tokumo, Yuki Yuasa, Hiromitsu Onoe, Naoki Okada, Shunsuke Nakakura, Ryo Asaoka, Yoshiaki Kiuchi

Abstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuta NakaniidaOphthalmology and Visual Science, Hiroshima University, Hiroshima, JPN.
Fumiko HigashikawaProbiotic Science for Preventive Medicine, Hiroshima University, Hiroshima, JPN.
Kana TokumoOphthalmology and Visual Science, Hiroshima University, Hiroshima, JPN.
Yuki YuasaOphthalmology and Visual Science, Hiroshima University, Hiroshima, JPN.
Hiromitsu OnoeOphthalmology and Visual Science, Hiroshima university, Hiroshima, JPN.
Naoki OkadaOphthalmology and Visual Science, Hiroshima University, Hiroshima, JPN.
Shunsuke NakakuraOphthalmology, Tsukazaki Hospital, Himeji, JPN.
Ryo AsaokaOphthalmology, Seirei Hamamatsu General Hospital, Hamamatsu, JPN.
Yoshiaki KiuchiOphthalmology and Visual Science, Hiroshima University, Hiroshima, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn binocular vision, there is a dominant eye and a nondominant eye, a phenomenon termed ocular dominance. This study determined the differences and associations of the ocular blood flow parameters between dominant and nondominant eyes in healthy Japanese subjects.

methodsThis cross-sectional study included 128 eyes of 64 subjects (13 male and 51 female) aged ≥ 20 years. The ocular blood flow parameters were assessed using laser speckle flowgraphy (LSFG), and software was used to calculate the mean blur rate (MBR), which reflects the blood flow velocity.

resultsThere were no significant differences in axial length (AL), spherical equivalent (SE), intraocular pressure (IOP), uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), or ocular blood flow parameters between the dominant and nondominant eyes. The ocular blood flow parameters of the dominant eye were significantly and positively correlated with those of the nondominant eye (all P < 0.001).

conclusionsNo significant differences in ocular blood flow parameters exist between the dominant and nondominant eyes in healthy subjects. The ocular blood flow parameters in the dominant eye are associated with those in the nondominant eye.

Indexed as

blood flow velocitylaser speckle flowgraphyocular blood flowocular dominanceoptic nerve head

Identifiers

PMID37927688
PMCPMC10624653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.